Antithrombotic Therapy Selection and Association With Clinical Outcomes Following Valve‐in‐Valve Transcatheter Aortic Valve Replacement
Anticoagulation was used more often than AP alone following ViV TAVR, but there were no significant differences in AV hemodynamics by echocardiography or clinical outcomes between antithrombotic groups through 1 year of follow-up.
Authors
- Vasilis Babaliaros (ORCID: https://orcid.org/0000-0002-9438-0846)
- Adam B. Greenbaum (ORCID: https://orcid.org/0000-0001-7496-5954)
- W. Brent Keeling (ORCID: https://orcid.org/0000-0003-3116-6495)
- Krishan Patel (ORCID: https://orcid.org/0000-0003-3120-4156)
- Hiroki Ueyama (ORCID: https://orcid.org/0000-0003-4812-7193)
- Isida Byku (ORCID: https://orcid.org/0000-0002-3951-6368)
- Chandan Devireddy (ORCID: https://orcid.org/0000-0002-6263-9411)
- Gaetano Paone (ORCID: https://orcid.org/0000-0002-6665-8329)
- Patrick Gleason (ORCID: https://orcid.org/0000-0001-5739-9030)
- George Hanzel (ORCID: https://orcid.org/0000-0003-3041-5947)
- John D’Angelo (ORCID: https://orcid.org/0009-0009-1146-9596)
- Joe Xie
Institutions
- Emory University (US)
- Emory University Hospital Midtown (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-11-30
- DOI
- https://doi.org/10.1002/ccd.70383
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00